Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4486 AL 4500

Effect of Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1 RA) on Neuropsychiatric Outcomes: A Systematic Review and Meta-Analysis

Choudhury I, Ward JH, Mahesh S, Alam U, Azmi S, Anson M.

Clin Ther. 2026 Apr;48(4):347-384. doi: 10.1016/j.clinthera.2026.02.010. Epub 2026 Mar 19.

Advances in the study of Parkinson's disease-related salivation and associated mechanisms

Han B, Wang L, Cui Y, Wang S, Zhao W, Wang S, Ma X, Xu X, Ma J, Zhu Y, Du Y, Tuo H.

Auton Neurosci. 2026 Apr;264:103396. doi: 10.1016/j.autneu.2026.103396. Epub 2026 Feb 17.

CVN-424: An Advanced GPR6 Inverse Agonist in Phase III Clinical Trials for Parkinson's Disease

Tian X, Ali S, Allen JA, Zhou J.

J Med Chem. 2026 Apr 9;69(7):7507-7511. doi: 10.1021/acs.jmedchem.6c00866.

Hearing Loss in Parkinson's Disease: A Systematic Review and Meta-Analysis

Rajai Firouzabadi S, Mohammadi I, Golsorkh H, Mahdavi S, Sadeghzadeh S, Rezaei K, Salari M.

Mov Disord. 2026 May;41(5):1069-1080. doi: 10.1002/mds.70206. Epub 2026 Jan 30.

Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative

Chahine LM, Alcalay RN, Brown EG, Chowdhury S, Coffey CS, Foroud T, Frasier M, Galasko D, Merchant KM, Mollenhauer B, Tolosa E, Pavese N, Tropea TF, Marek K, Simuni T; Parkinson's Progression Markers Initiative.

Ann Neurol. 2026 Oct;100 Suppl 38:S53-S62. doi: 10.1002/ana.78249. Epub 2026 May 6.

Parkinson's Disease and Voluntary Walking Interventions-A Systematic Review and Meta-analysis

Kloster CT, Bonde-Jensen F, Langeskov-Christensen M, Dalgas U.

Arch Phys Med Rehabil. 2026 Jan 31:S0003-9993(26)00048-1. doi: 10.1016/j.apmr.2026.01.024. Online ahead of print.

Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-naïve Parkinson's disease: a randomized phase 2 trial

Zhang R, Feng R, Wang J, Chen Y, Liu H, Zhu Q, Tian H, Qin C, Teng J, Tang B, Wu M, Zeng J, Wu E, Ding X, Wang X.

Signal Transduct Target Ther. 2026 Mar 13;11(1):94. doi: 10.1038/s41392-026-02604-9.

Return of Individual Research Information in the Parkinson's Progression Markers Initiative

Tropea TF, Brodkin K, Brumm MC, Carley JK, Destro C, Flagg E, Heathers LEA, Henry B, Lemon LP, Kuhl MM, McMahon BA, Miller M, Myers H, Stanley CE Jr, Talarico JM, Pico C, Chahine LM, Siderowf A, Marek K, Foroud T; Parkinson's Progression Markers Initiative.

Ann Neurol. 2026 Oct;100 Suppl 38:S88-S96. doi: 10.1002/ana.78228. Epub 2026 Apr 29.

Closing the Gap: Telepsychology and Quality of Life in Parkinson's Disease

Patel B, Pontone GM.

Am J Geriatr Psychiatry. 2026 Apr;34(4):434-436. doi: 10.1016/j.jagp.2025.12.019. Epub 2026 Jan 10.

When the conductor is right on cue…

Gülke E, Lewis S.

Pract Neurol. 2026 Jan 13;26(1):2-3. doi: 10.1136/pn-2025-004614.

Visual perturbation training to reduce visual dependency in Parkinson's disease: A randomized controlled trial

Baggen RJ, Van Bladel A, Prins MR, Stappers J, Spildooren J, De Letter M, Bouche K, Cambier D, Maes L, Santens P.

PLoS One. 2026 Mar 2;21(3):e0343223. doi: 10.1371/journal.pone.0343223. eCollection 2026.

Perioperative Inflammatory Cytokines in Parkinson's Disease

Kim JW, Yoo SA, Choi Y, Jeong GH, Lee J, Joo J.

Biomolecules. 2026 Feb 5;16(2):261. doi: 10.3390/biom16020261.

Neurology Under Fire: What About Parkinson's Disease in Wartime?

Fabbri M, Rascol O.

Mov Disord. 2026 May 1. doi: 10.1002/mds.70350. Online ahead of print.

The Parkinson's Progression Markers Initiative: Why Then? Why Now?

Fox MJ.

Ann Neurol. 2026 Oct;100 Suppl 38:S8-S9. doi: 10.1002/ana.78192. Epub 2026 Mar 23.

Skin intraneural phosphorylated α-synuclein is a highly specific biomarker for early Parkinson's disease

Donadio V, Incensi A, Rizzo G, Furia A, Bonvenga S, Olivola E, Piatti M, Ventruto F, Vacchiano V, Delprete C, Ingelsson M, Modugno N, Postuma R, Cilia R, Liguori R.

Brain. 2026 Mar 5;149(3):856-866. doi: 10.1093/brain/awaf313.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias